TY  - JOUR

T1  - Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma

JO  - AM J CLIN ONCOL-CANC

PY  - 2005/02/01

AU  - Reed SD

AU  - Radeva JI

AU  - Glendenning GA

AU  - Coleman RE

AU  - Schulman KA

ED  - 

DO  - DOI: 10.1097/01.coc.0000138966.66780.3e

VL  - 28

IS  - 1

SP  - 8

EP  - 16

Y2  - 2025/10/10

ER  -